Gemcitabine-Induced Autophagy Protects Human Lung Cancer Cells from Apoptotic Death
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gemcitabine-Induced Autophagy Protects Human Lung Cancer Cells from Apoptotic Death
Authors
Keywords
Lung cancer, Gemcitabine, Autophagy, Apoptosis, Chemoresistance
Journal
LUNG
Volume 194, Issue 6, Pages 959-966
Publisher
Springer Nature
Online
2016-09-08
DOI
10.1007/s00408-016-9936-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Acquired resistance to gemcitabine and cross-resistance in human pancreatic cancer clones
- (2015) Hiroshi Yoneyama et al. ANTI-CANCER DRUGS
- Autophagy and gap junctional intercellular communication inhibition are involved in cadmium-induced apoptosis in rat liver cells
- (2015) Hui Zou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (−)-Gossypol (AT-101)
- (2015) Jens Mani et al. BMC CANCER
- Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells
- (2015) Hui-Mei Wu et al. Scientific Reports
- GDC-0980-induced apoptosis is enhanced by autophagy inhibition in human pancreatic cancer cells
- (2014) Jian-ying Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Autophagy inhibits chemotherapy-induced apoptosis through downregulating Bad and Bim in hepatocellular carcinoma cells
- (2014) Yan Zhou et al. Scientific Reports
- Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine
- (2013) Daniela Laura Papademetrio et al. Targeted Oncology
- Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation
- (2013) A Notte et al. Cell Death & Disease
- Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics
- (2011) Tracey R. O’Donovan et al. Autophagy
- Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO in regulating programmed cell death
- (2011) K K W Hui et al. CELL DEATH AND DIFFERENTIATION
- p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death
- (2011) Xi Feng et al. EMBO JOURNAL
- Autophagy and disease: always two sides to a problem
- (2011) Sunandini Sridhar et al. JOURNAL OF PATHOLOGY
- Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines
- (2011) Giuseppe Pasqualetti et al. LUNG CANCER
- Fifty years of cancer incidence: CI5 I-IX
- (2010) D. Max Parkin et al. INTERNATIONAL JOURNAL OF CANCER
- Gemcitabine Induces the VMP1 -Mediated Autophagy Pathway to Promote Apoptotic Death in Human Pancreatic Cancer Cells
- (2010) Romina Pardo et al. PANCREATOLOGY
- Inhibition of Autophagy by 3-MA Enhances the Effect of 5-FU-Induced Apoptosis in Colon Cancer Cells
- (2009) Jie Li et al. ANNALS OF SURGICAL ONCOLOGY
- Autophagy Inhibition Enhances Apoptosis Induced by Ginsenoside Rk1 in Hepatocellular Carcinoma Cells
- (2009) Hyeonseok KO et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice
- (2009) Tai-Guo Liu et al. BMC CANCER
- Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells
- (2009) Donglei Liu et al. MEDICAL ONCOLOGY
- Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3 and BNIP3L
- (2008) I Papandreou et al. CELL DEATH AND DIFFERENTIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More